Skip to main navigation Skip to search Skip to main content

A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors

  • Paolo Anderlini
  • , Michele Donato
  • , Mary J. Lauppe
  • , Yang O. Huh
  • , Thomas G. Martin
  • , Ka Wah Chan
  • , Richard E. Champlin
  • , Martin Körbling
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

Eighty-one first-time normal donors underwent leukapheresis for peripheral blood progenitor cell (PBPC) collection after mobilization with filgrastim administered either twice-daily (6 μg/kg every 12 h: n = 40) or once-daily (12 μg/kg: n = 41) subcutaneously for 3 d. The groups were similar for age, donor blood volume and target CD34+ cell dose to be collected (≤ 4 x 106 CD34+ cells/kg recipient). There was no statistically significant difference in the apheresis yield of CD34+ PBPCs (x 106) per kg recipient weight (5·6 ± 3·3 vs. 5·6 ± 4·3: P = 0·94) and per litre of blood processed (30± 17·2 vs. 30·4 ± 19·5: P = 0·92).

Original languageEnglish
Pages (from-to)770-772
Number of pages3
JournalBritish Journal of Haematology
Volume109
Issue number4
DOIs
StatePublished - 2000

Keywords

  • Filgrastim
  • Granulocyte colony- stimulating factor
  • Leukapheresis
  • Normal donors
  • Peripheral blood progenitor cell mobilization

Fingerprint

Dive into the research topics of 'A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors'. Together they form a unique fingerprint.

Cite this